Blinded sample size recalculation in adaptive enrichment designs
From MaRDI portal
Publication:6550297
DOI10.1002/bimj.202000345zbMATH Open1539.62328MaRDI QIDQ6550297
Publication date: 5 June 2024
Published in: Biometrical Journal (Search for Journal in Brave)
Cites Work
- Basic concepts of group sequential and adaptive group sequential test procedures
- Comparison of design strategies for a three-arm clinical trial with time-to-event endpoint: Power, time-to-analysis, and operational aspects
- Internal pilots for observational studies
- Adaptive Group Sequential Designs for Clinical Trials: Combining the Advantages of Adaptive and of Classical Group Sequential Approaches
- On closed testing procedures with special reference to ordered analysis of variance
- Designed Extension of Studies Based on Conditional Power
- On the Use of the Upper Confidence Limit for the Variance from a Pilot Sample for Sample Size Determination
- Evaluation of Experiments with Adaptive Interim Analyses
- Blinded and unblinded sample size reestimation procedures for stepped‐wedge cluster randomized trials
- Blinded and unblinded sample size reestimation in crossover trials balanced for period
- Methods and Applications of Sample Size Calculation and Recalculation in Clinical Trials
- Confirmatory Seamless Phase II/III Clinical Trials with Hypotheses Selection at Interim: General Concepts
- Confirmatory Seamless Phase II/III Clinical Trials with Hypotheses Selection at Interim: Applications and Practical Considerations
- Adaptive seamless clinical trials using early outcomes for treatment or subgroup selection: Methods, simulation model and their implementation in R
- Sample size recalculation in multicenter randomized controlled clinical trials based on noncomparative data
- Optimal promising zone designs
- A conditional error function approach for adaptive enrichment designs with continuous endpoints
- Sample size re-estimation for clinical trials with longitudinal negative binomial counts including time trends
- Blinded continuous monitoring of nuisance parameters in clinical trials
This page was built for publication: Blinded sample size recalculation in adaptive enrichment designs